M John Chapman
M John Chapman is an expert in Cardiology at Pitié-Salpêtrière Hospital (France). As of October 2026, ScienceLeadR ranks M John Chapman in the top 1% of experts worldwide for Dyslipidemias, Lipid Metabolism Disorders and Arteriosclerosis. M John Chapman has authored 284 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 883 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Pharmacy - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1987 - 2026
Number : 284
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Bioactive lipids in plasma and atherogenic apoB-containing lipoproteins: Effects of statins and PCSK9 inhibitors and relevance to residual cardiovascular risk. PMID 42162924 — sphingolipids, lipoproteins, dyslipidemias, phosphatidylinositols, secondary prevention, cholesterol, phosphatidylcholines, pharmacology, ceramides, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, esters, apolipoproteins b, plasma | Pharmacol Ther | 2026 | 0 |
| Editorial: The Brussels International Declaration on Lp(a) Testing And Management-A call to action. PMID 40374489 — research design, arteriosclerosis | Atherosclerosis | 2025 | 0 |
| Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte? PMID 39947256 — cells, hepatocytes, cholesterol, ldl, pharmaceutical preparations, rna, small interfering, pharmacology, therapeutics, plasma | Pharmacol Ther | 2025 | 0 |
| Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution. PMID 39880548 — cardiology, triglycerides, plasma | J Am Coll Cardiol | 2025 | 0 |
| DO BIOACTIVE LIPIDS IMPACT HDLVASOPROTECTIVE FUNCTION IN HYPERTRIGLYCERIDEMIA? OpenAlex W4404972438 — hypertriglyceridemia, lipids | Atherosclerosis | 2024 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map